(Q46069840)

19 December 2017

title

Familial and sporadic hemiplegic migraine: diagnosis and treatment (English)

1 reference

19 December 2017

1 reference

5

Gisela M Terwindt

1 reference

19 December 2017

4

Michel D Ferrari

1 reference

19 December 2017

Nadine Pelzer

1

1 reference

19 December 2017

Anine H Stam

series ordinal

2

1 reference

19 December 2017

Joost Haan

series ordinal

3

1 reference

19 December 2017

publication date

1 February 2013

1 reference

19 December 2017

Current treatment options in neurology

published in

1 reference

19 December 2017

volume

15

1 reference

19 December 2017

issue

1

1 reference

19 December 2017

page(s)

13-27

1 reference

19 December 2017

https://scigraph.springernature.com/pub.10.1007/s11940-012-0208-3

exact match

0 references

cites work

An epidemiological survey of hemiplegic migraine

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Migraine--current understanding and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Pathophysiology of the migraine aura. The spreading depression theory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Focal hyperemia followed by spreading oligemia and impaired activation of rcbf in classic migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Mechanisms of migraine aura revealed by functional MRI in human visual cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Ergotamine and dihydroergotamine: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Clinical and experimental effects of sumatriptan in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Migraine headache is not associated with cerebral or meningeal vasodilatation--a 3T magnetic resonance angiography study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Evidence for a vascular factor in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Migraine and genetic and acquired vasculopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Increased risk of migraine with typical aura in probands with familial hemiplegic migraine and their relatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Implications of clinical subtypes of migraine with aura

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Is familial hemiplegic migraine a hereditary form of basilar migraine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Sporadic and familial hemiplegic migraine: pathophysiological mechanisms, clinical characteristics, diagnosis, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Delayed cerebral edema and fatal coma after minor head trauma: role of the CACNA1A calcium channel subunit gene and relationship with familial hemiplegic migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Variability of familial hemiplegic migraine with novel A1A2 Na+/K+-ATPase variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Molecular genetics of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Expanding the phenotypic spectrum of the CACNA1A gene T666M mutation: a description of 5 families with familial hemiplegic migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

ATP1A2 mutations in 11 families with familial hemiplegic migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Severe attacks of familial hemiplegic migraine, childhood epilepsy and ATP1A2 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Severe episodic neurological deficits and permanent mental retardation in a child with a novel FHM2 ATP1A2 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

A G301R Na+/K+ -ATPase mutation causes familial hemiplegic migraine type 2 with cerebellar signs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

The genetic spectrum of a population-based sample of familial hemiplegic migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Detection of a novel mutation in the CACNA1A gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Screen for CACNA1A and ATP1A2 Mutations in Sporadic Hemiplegic Migraine Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Mutation analysis of the CACNA1A calcium channel subunit gene in 27 patients with sporadic hemiplegic migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

CACNA1A gene de novo mutation causing hemiplegic migraine, coma, and cerebellar atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Serial MRI in a case of familial hemiplegic migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Sporadic hemiplegic migraine presenting as acute encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Sporadic hemiplegic migraine: report of a case with clinical and radiological features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Imaging abnormalities in sporadic hemiplegic migraine on conventional MRI, diffusion and perfusion MRI and MRS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Opening of the blood-brain barrier preceding cortical edema in a severe attack of FHM type II

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Implication of augmented vasogenic leakage in the mechanism of persistent aura in sporadic hemiplegic migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Intravenous nimodipine worsening prolonged attack of familial hemiplegic migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

New CACNA1A gene mutation in a case of familial hemiplegic migraine with status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Prolonged cortical electrical depression and diffuse vasospasm without ischemia in a case of severe hemiplegic migraine during pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

A novel ATP1A2 mutation in a family with FHM type II

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Hemiplegic migraine with CSF abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Pseudomigraine with temporary neurological symptoms and lymphocytic pleocytosis. A report of 50 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

The transient syndrome of headache with neurologic deficits and CSF lymphocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Abnormal MRI in a patient with 'headache with neurological deficits and CSF lymphocytosis (HaNDL)'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Diffusion restriction in the splenium of the corpus callosum in a patient with the syndrome of transient headache with neurological deficits and CSF lymphocytosis (HaNDL): a challenge to the diagnostic criteria?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Pseudomigraine with lymphocytic pleocytosis: a calcium channelopathy? Clinical description of 10 cases and genetic analysis of the familial hemiplegic migraine gene CACNA1A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

De novo mutations in ATP1A3 cause alternating hemiplegia of childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

MELAS syndrome: Characteristic migrainous and epileptic features and maternal transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Trigger factors for familial hemiplegic migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Is stress a trigger factor for migraine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Safety and efficacy of flunarizine in childhood migraine: 11 years' experience, with emphasis on its effect in hemiplegic migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

The effects of verapamil and diltiazem on N-, P- and Q-type calcium channels mediating dopamine release in rat striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Familial hemiplegic migraine and its abortive therapy with intravenous verapamil

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Treatment of sporadic hemiplegic migraine with calcium-channel blocker verapamil

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Possible mechanisms of valproate in migraine prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

EFNS guideline on the drug treatment of migraine--revised report of an EFNS task force

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Persistent migrainous visual phenomena might be responsive to lamotrigine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Lamotrigine in the prophylactic treatment of migraine aura--a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Effectiveness of lamotrigine in the prophylaxis of migraine with aura: an open pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Lamotrigine reduces migraine aura and migraine attacks in patients with migraine with aura

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Preventing disturbing migraine aura with lamotrigine: an open study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

21 January 2018

Episodic ataxia type 2.

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

A new CACNA1A gene mutation in acetazolamide-responsive familial hemiplegic migraine and ataxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Acetazolamide responsiveness in familial hemiplegic migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Off-label use of acetazolamide in a patient with familial hemiplegic migraine and concomitant psychotic episodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Acetazolamide efficacy and tolerability in migraine with aura: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Efficacy and tolerability of acetazolamide in migraine prophylaxis: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Migraine: preventive treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Topiramate-associated worsening symptoms in a patient with familial hemiplegic migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Isoproterenol and propranolol: ability to cross the blood-brain barrier and effects on cerebral circulation in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Hemiplegic migraine in childhood: diagnostic and therapeutic aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Hemiplegic migraine: hyperperfusion and abortive therapy with intravenous verapamil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Genetic diagnosis and acetazolamide treatment of familial hemiplegic migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Ergotamine in the acute treatment of migraine: a review and European consensus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Coronary side-effect potential of current and prospective antimigraine drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Triptans in the treatment of basilar migraine and migraine with prolonged aura

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Ketamine: its mechanism(s) of action and unusual clinical uses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Aura in some patients with familial hemiplegic migraine can be stopped by intranasal ketamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Randomized, controlled trial of telcagepant for the acute treatment of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

New Agents for Acute Treatment of Migraine: CGRP Receptor Antagonists, iNOS Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Neurostimulation for primary headache disorders, part 1: pathophysiology and anatomy, history of neuromodulation in headache treatment, and review of peripheral neuromodulation in primary headaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

De novo mutations in ATP1A2 and CACNA1A are frequent in early-onset sporadic hemiplegic migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Familial hemiplegic migraine and autosomal dominant arteriopathy with leukoencephalopathy (CADASIL)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0208-3

Stroke in migraine as a consequence of propranolol

21 January 2018

1 reference

12 December 2020

Lamotrigine versus placebo in the prophylaxis of migraine with and without aura

1 reference

12 December 2020

Treatment of hemiplegic migraine with triptans

1 reference

12 December 2020

A case of hemiplegic migraine treated with flunarizine

1 reference

12 December 2020

Successful treatment of persistent migraine aura with divalproex sodium

1 reference

12 December 2020

Lamotrigine inhibits Ca2+ currents in cortical neurons: functional implications

1 reference

12 December 2020

Opening of the blood-brain barrier preceding cortical edema in a severe attack of FHM type II.

1 reference

12 December 2020

The International Classification of Headache Disorders: 2nd edition

1 reference

12 December 2020

Flunarizine blocks voltage-gated Na(+) and Ca(2+) currents in cultured rat cortical neurons: A possible locus of action in the prevention of migraine

1 reference

12 December 2020

An association between migraine and cutaneous allodynia.

1 reference

12 December 2020

Familial hemiplegic migraine presenting as recurrent encephalopathy in a Native Indian family

1 reference

12 December 2020

An autosomal dominant syndrome of hemiplegic migraine, nystagmus, and tremor

1 reference

12 December 2020

Familial hemiplegic migraine with irreversible brain damage.

1 reference

12 December 2020

Hemiplegic migraine induced by exertion

1 reference

12 December 2020

Systematic analysis of three FHM genes in 39 sporadic patients with hemiplegic migraine

1 reference

12 December 2020

A case of familial hemiplegic migraine associated with a novel ATP1A2 gene mutation

1 reference

12 December 2020

Magnetic resonance angiogram evidence of vasospasm in familial hemiplegic migraine

1 reference

12 December 2020

10.1007/S11940-012-0208-3

Identifiers

DOI

1 reference

19 December 2017

1 reference

19 December 2017